Abstract:Background: Ascomycin is a 23-membered polyketide macrolide with high immunosuppressant and antifungal activity. As the lower production in bio-fermentation, global metabolic analysis is required to further explore its bio-synthetic network and determine the key limiting steps for rationally engineering. To achieve this goal, an engineering approach guided by a metabolic network model was implemented to better understand ascomycin biosynthesis and improve its production. Results: The metabolic conservation of Streptomyces species was first investigated by comparing the metabolic enzymes of Streptomyces coelicolor A3(2) with those of 31 Streptomyces strains, the results showed that more than 72% of the examined proteins had high sequence similarity with counterparts in every surveyed strain. And it was found that metabolic reactions are more highly conserved than the enzymes themselves because of its lower diversity of metabolic functions than that of genes. The main source of the observed metabolic differences was from the diversity of secondary metabolism. According to the high conservation of primary metabolic reactions in Streptomyces species, the metabolic network model of Streptomyces hygroscopicus var. ascomyceticus was constructed based on the latest reported metabolic model of S. coelicolor A3(2) and validated experimentally. By coupling with flux balance analysis and using minimization of metabolic adjustment algorithm, potential targets for ascomycin overproduction were predicted. Since several of the preferred targets were highly associated with ethylmalonyl-CoA biosynthesis, two target genes hcd (encoding 3-hydroxybutyryl-CoA dehydrogenase) and ccr (encoding crotonyl-CoA carboxylase/reductase) were selected for overexpression in S. hygroscopicus var. ascomyceticus FS35. Both the mutants HA-Hcd and HA-Ccr showed higher ascomycin titer, which was consistent with the model predictions. Furthermore, the combined effects of the two genes were evaluated and the strain HA-Hcd-Ccr with hcd and ccr overexpression exhibited the highest ascomycin production (up to 438.95 mg/L), 1.43-folds improvement than that of the parent strain FS35 (305.56 mg/L). Conclusions: The successful constructing and experimental validation of the metabolic model of S. hygroscopicus var. ascomyceticus showed that the general metabolic network model of Streptomyces species could be used to analyze the intracellular metabolism and predict the potential key limiting steps for target metabolites overproduction. The corresponding overexpression strains of the two identified genes (hcd and ccr) using the constructed model all displayed higher ascomycin titer. The strategy for yield improvement developed here could also be extended to the improvement of other secondary metabolites in Streptomyces species.

Enhancement of FK520 Production in Streptomyces Hygroscopicus by Combining Traditional Mutagenesis with Metabolic Engineering.

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Enhancement of FK506 Production by Engineering Secondary Pathways of Streptomyces Tsukubaensis and Exogenous Feeding Strategies

Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement

Improvement of FK506 Production in Streptomyces Tsukubaensis by Genetic Enhancement of the Supply of Unusual Polyketide Extender Units Via Utilization of Two Distinct Site-Specific Recombination Systems

Improved FK506 Production by the Precursors and Product-Tolerant Mutant of Streptomyces Tsukubaensis Based on Genome Shuffling and Dynamic Fed-Batch Strategies

Improvement of FK 506 Production by Selection of 4-Aminobutyric Acid-tolerant Mutant and Optimization of its Fermentation Using Response Surface Methodology

Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis.

Generation of Streptomyces Hygroscopicus Cell Factories with Enhanced Ascomycin Production by Combined Elicitation and Pathway-Engineering Strategies

Boosting ascomycin production by n-butanol addition in fermentation of Streptomyces hygroscopicus var. ascomyceticus ATCC 14891

Reduction of Foaming and Enhancement of Ascomycin Production in Rational Streptomyces Hygroscopicus Fermentation

Elevation of FK506 Production by Regulatory Pathway Engineering and Medium Optimization in Streptomyces Tsukubaensis

Higher-level Production of Ascomycin (FK520) by Streptomyces Hygroscopicus Var. Ascomyceticus Irradiated by Femtosecond Laser

Production Improvement of FK506 in Streptomyces Tsukubaensis by Metabolic Engineering Strategy

Balancing carbon flux rebalancing around phosphoenolpyruvate node for enhancement of FK506 production in Streptomyces tsukubaensis

Metabolic Network Model Guided Engineering Ethylmalonyl-Coa Pathway to Improve Ascomycin Production in Streptomyces Hygroscopicus Var. Ascomyceticus.

Integration Of Parallel C-13-Labeling Experiments And In Silico Pathway Analysis For Enhanced Production Of Ascomycin

Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis

Increasing the Ascomycin Yield by Relieving the Inhibition of Acetyl/Propionyl-CoA Carboxylase by the Signal Transduction Protein GlnB

Improving the Production of the Micafungin Precursor FR901379 in an Industrial Production Strain

Engineering of the LysR Family Transcriptional Regulator FkbR1 and Its Target Gene to Improve Ascomycin Production